Ventuno Biotech
Latest round
- Seed
Last raised
- Nov 2025
Total raised
- $1.8M
Investors
- 2
About Ventuno Biotech
Ventuno Biotech, founded in 2025 in Lyon, France, focuses on cancer immunotherapies.Ventuno Biotech is focused on developing innovative cancer therapies that leverage the immune system's capabilities to target and eliminate cancer cells, particularly in difficult-to-treat tumors. Their core offerings are centered around next-generation cancer immunotherapies that aim to enhance the body’s immune response against cancer. The company's products are designed for healthcare providers, including hospitals and oncology clinics, and serve patients diagnosed with various forms of cancer. Ventuno Biotech’s therapeutic solutions are marketed primarily in Europe and are tailored for regions where there is a significant need for advanced cancer treatment options.Ventuno Biotech generates revenue through a structure that includes partnerships with healthcare institutions and direct sales of their immunotherapy products. The company is engaged in B2B transactions, primarily targeting hospitals and oncology centers that incorporate these advanced treatments into their patient care protocols. Revenue streams are bolstered by collaboration agreements and potential licensing of their proprietary technologies to larger pharmaceutical companies. Pricing plans for the products are structured around specific treatment regimens, and the company establishes agreements that ensure consistent supply and access for its therapeutic offerings. The company is focused on designing and launching new products that enhance its cancer treatment portfolio. Plans for expanding into new markets include targeting additional regions across Europe by the end of 2026, aligning with their goal to address the urgent needs of cancer patients globally.
Who invested in Ventuno Biotech
2 investors across 1 round
See all investors in Ventuno Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 12, 2025
Amount
$1.8M
Investors
Questions about Ventuno Biotech
Who invested in Ventuno Biotech?
Ventuno Biotech has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ventuno Biotech raised?
Ventuno Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ventuno Biotech last raise money?
Ventuno Biotech's most recent round on record is a Seed, in Nov 2025.
What does Ventuno Biotech do?
Ventuno Biotech, founded in 2025 in Lyon, France, focuses on cancer immunotherapies.
Where is Ventuno Biotech headquartered?
Ventuno Biotech is headquartered in Lyon, France.
Which VCs invest in companies like Ventuno Biotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Ventuno Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ventuno Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.